Mesonephric adenocarcinoma with a sarcomatous component, a notable subtype of cervical carcinosarcoma: a case report and review of the literature

Table 1 Antibodies used for immunohistochemical staining and its results

Antigen	Antibodies			Results
	Clone	Source	Dilution	Biopsy	Hysterectomy
					Adenoca.	Sarscomatous component
AE1/AE3	AE1/AE3	Dako, Glostrup, Denmark	1: 50	+	+++	-
CAM5.2	CAM5.2	BD Biosciences, California, USA	1: 2	ND*	+++	-
vimentin	V9	Dako	1: 100	+++	-	+++
ER	SP1	Roche Diagnostics, Basel, Switzerland	1: 1	-	-	-
PgR	1E2	Roche Diagnostics	1: 1	-	-	-
AR	AR441	Dako	1: 50	ND*	-	-
CD10	56C6	Leica Microsystems, Newcastle, UK	1: 40	-	++	++
calretinin	5A5	Leica Microsystems	1: 100	-	+	-

ND*, not done.
Immunopositivity was semi-quantitatively assessed as follows: 3+, more than 10% of the tumor cells positive; 2+, 1-10% of the tumor cells positive; 1+, less than 1% tumor cells positive; no tumor cell staining was considered negative.

ISSN: 1746-1596